trending Market Intelligence /marketintelligence/en/news-insights/trending/dyhnrmkbkuz24qfpuzx9wa2 content esgSubNav
In This List

Aeglea BioTherapeutics appoints director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Aeglea BioTherapeutics appoints director

Aeglea Biotherapeutics Inc. appointed Ivana Magovcevic-Liebisch as a director.

Magovcevic-Liebisch is the executive vice president and chief business officer of Ipsen SA, a global biopharmaceutical company.

Austin, Texas-based Aeglea Biotherapeutics is a biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.